These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Hepatic overexpression of caveolins increases bile salt secretion in mice. Moreno M; Molina H; Amigo L; Zanlungo S; Arrese M; Rigotti A; Miquel JF Hepatology; 2003 Dec; 38(6):1477-88. PubMed ID: 14647059 [TBL] [Abstract][Full Text] [Related]
11. Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation. van Eijk M; Aten J; Bijl N; Ottenhoff R; van Roomen CP; Dubbelhuis PF; Seeman I; Ghauharali-van der Vlugt K; Overkleeft HS; Arbeeny C; Groen AK; Aerts JM PLoS One; 2009; 4(3):e4723. PubMed ID: 19305508 [TBL] [Abstract][Full Text] [Related]
12. Hepatic glycosphingolipid deficiency and liver function in mice. Jennemann R; Rothermel U; Wang S; Sandhoff R; Kaden S; Out R; van Berkel TJ; Aerts JM; Ghauharali K; Sticht C; Gröne HJ Hepatology; 2010 May; 51(5):1799-809. PubMed ID: 20432257 [TBL] [Abstract][Full Text] [Related]
13. Effects of isoxazolidine or triazolidine on rat serum lipids in vivo and LDL and HDL binding and degradation in human and rodent cultured cells in vitro. Hall IH; Wong OT; Simlot R; Izydore RA Res Commun Chem Pathol Pharmacol; 1992 Sep; 77(3):327-46. PubMed ID: 1333628 [TBL] [Abstract][Full Text] [Related]
14. The Iminosugar AMP-DNM Improves Satiety and Activates Brown Adipose Tissue Through GLP1. Herrera Moro Chao D; Wang Y; Foppen E; Ottenhoff R; van Roomen C; Parlevliet ET; van Eijk M; Verhoek M; Boot R; Marques AR; Scheij S; Mirzaian M; Kooijman S; Jansen K; Wang D; Mergen C; Seeley RJ; Tschöp MH; Overkleeft H; Rensen PCN; Kalsbeek A; Aerts JMFG; Yi CX Diabetes; 2019 Dec; 68(12):2223-2234. PubMed ID: 31578192 [TBL] [Abstract][Full Text] [Related]
15. Biliary lipid secretion, bile acid metabolism, and gallstone formation are not impaired in hepatic lipase-deficient mice. Amigo L; Mardones P; Ferrada C; Zanlungo S; Nervi F; Miquel JF; Rigotti A Hepatology; 2003 Sep; 38(3):726-34. PubMed ID: 12939599 [TBL] [Abstract][Full Text] [Related]
16. Effects of obesity and caloric intake on biliary lipid metabolism in man. Bennion LJ; Grundy SM J Clin Invest; 1975 Oct; 56(4):996-1011. PubMed ID: 1159099 [TBL] [Abstract][Full Text] [Related]
17. Chronic pharmacological activation of P2Y13 receptor in mice decreases HDL-cholesterol level by increasing hepatic HDL uptake and bile acid secretion. Serhan N; Cabou C; Verdier C; Lichtenstein L; Malet N; Perret B; Laffargue M; Martinez LO Biochim Biophys Acta; 2013 Apr; 1831(4):719-25. PubMed ID: 23266391 [TBL] [Abstract][Full Text] [Related]
18. Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia. Grundy SM J Clin Invest; 1975 Feb; 55(2):269-82. PubMed ID: 233943 [TBL] [Abstract][Full Text] [Related]
19. Effect of the prokinetic agent, erythromycin, in the Richardson ground squirrel model of cholesterol gallstone disease. Xu QW; Scott RB; Tan DT; Shaffer EA Hepatology; 1998 Sep; 28(3):613-9. PubMed ID: 9731548 [TBL] [Abstract][Full Text] [Related]
20. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis. Nilsell K; Angelin B; Leijd B; Einarsson K Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]